Alto Neuroscience - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAlto Neuroscience
Alto Neuroscience logo

Alto Neuroscience

0 followers

ANRO

Performance

About Alto Neuroscience

Alto Neuroscience is a biotechnology company focused on neuropsychiatry, leveraging brain biology to develop personalized medicines for psychiatric conditions. The company emphasizes precision approaches to predict clinical response and identify patients most likely to benefit from its drug candidates, with an initial focus on major depressive disorder, bipolar depression, and schizophrenia. Based in Mountain View, California, Alto combines deep neurobiology research with a clinical-stage pipeline to disrupt traditional trial-and-error treatment in psychiatry.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Jessica Powell

Chief Development Officer

Michael Hanley

Chief Operating Officer

Erin R. McQuade

General Counsel and Chief Administrative Officer

Adam Savitz, MD, PhD

Chief Medical Officer

Amit Etkin, MD, PhD

Founder, President, and Chief Executive Officer

Key Facts

HQ Location

Mountain View, United States

Founded

2019

Employees

51 - 200

Status

Public

Website

https://altoneuroscience.com